Literature DB >> 36111180

Isolated congenital interruption of the right interlobar pulmonary artery with unilateral interstitial lung abnormality.

Mitsukuni Sakabe1, Kazunori Tobino1,2, Kazuki Uchida1, Yosuke Murakami1, Yuri Hiramatsu1, Hiroaki Ota1, Takafumi Kawabata1.   

Abstract

We report a case of an isolated congenital interruption of the right interlobar pulmonary artery with unilateral interstitial lung abnormality. 3D-CT with enhancement showed absent right interlobar pulmonary artery without any other abnormalities of the pulmonary artery and an enlarged inferior phrenic artery. High-resolution CT demonstrated ground-glass opacities, reticular changes, and small cysts in the right middle and lower lobes, which were compatible with interstitial lung abnormality. The patient was diagnosed with an isolated congenital interruption of the right interlobar pulmonary artery since chronic pulmonary thromboembolism, structural heart disease, systemic congenital disease, and systemic vasculitis were ruled out.
© 2022 The Authors.

Entities:  

Keywords:  Congenital interruption of right interlobar pulmonary artery CT; ECG, Electrocardiography; Interstitial lung abnormality; PE, Pulmonary embolism; UIP, Usual interstitial pneumonia

Year:  2022        PMID: 36111180      PMCID: PMC9467893          DOI: 10.1016/j.rmcr.2022.101734

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Isolated congenital interruption of the right interlobar pulmonary artery is an extremely rare condition. To the best of our knowledge, only one case report has described the chest computed tomography (CT) findings of this condition, which showed unilateral interstitial changes in the middle and lower lobes of the right lung. In this report, usual interstitial pneumonia (UIP) pattern-like lesions such as bronchial dilatation, ground-glass opacities, reticular changes, and honeycombing in the right lower lung lobe were observed. These abnormalities were thought to be due to changes in blood flow owing to pulmonary artery defects. We report a case with CT imaging findings that differ from the previous report.

Case presentation

A 62-year-old female patient was referred to our hospital for suspected recurrent pulmonary embolism (PE). She complained of dry cough and chest pain for 2 days. Eighteen months previously, she was found to have abnormal electrocardiography (ECG) patterns (i.e., nonspecific T-wave abnormalities) without any symptoms and was diagnosed with PE of the right interlobar pulmonary artery on CT perfusion scan. Since then, she had been treated with warfarin; however, her condition and ECG patterns remain unchanged. She had no other medical history and had never smoked. Her oxygen saturation was 94% at room air and her other vital signs were normal. A physical examination revealed normal breathing and cardiac sounds and no edema. Laboratory test values were as follows: white blood cells, 5660/mm3; hemoglobin, 11.6 g/dl; platelets, 115,000/mm3; serum lactate dehydrogenase, 223 U/l (normal, 119–229 U/l); serum aspartate and alanine aminotransferase, 34 U/l and 19 U/l (normal, 0–35 U/l); serum albumin, 2.8 g/dl (normal, 4–5 g/dl); serum C-reactive protein, 0.57 mg/dl (normal, < 0.2 mg/dl); serum D-dimer, < 0.5 μg/ml (normal, < 0.5 μg/ml); and brain natriuretic peptide, 631.2 pg/ml. Serum protein C and protein S activity were normal, and antinuclear antibody, anti-phospholipid antibody, PR3-ANCA and MPO-ANCA assays were negative. ECG showed nonspecific T-wave abnormalities. Transthoracic echocardiography revealed normal chamber sizes, normal left ventricular function, and no evidence of other structural heart diseases. Chest radiograph showed reticular changes in the right middle and lower lung fields without volume change (Fig. 1). 3D-CT with enhancement showed absent right interlobar pulmonary artery without any other abnormalities of the pulmonary artery, and an enlarged inferior phrenic artery (Fig. 2). High-resolution CT demonstrated ground-glass opacities, reticular changes, and small cysts in the right middle and lower lobes (Fig. 3), which were compatible with interstitial lung abnormality. Lung perfusion scan showed total defect in the right middle and lower lobes (Fig. 4). The patient was diagnosed with an isolated congenital interruption of the right interlobar pulmonary artery, since chronic PE, structural heart disease, systemic congenital disease, and systemic vasculitis were ruled out. Her symptoms improved on the 2nd day of admission, and her condition stabilized without any treatment. Therefore, it was considered that there was no relationship between her symptoms and the isolated congenital interruption of the right interlobar pulmonary artery.
Fig. 1

Chest radiograph shows reticular opacities in the right middle and lower lung field without volume change.

Fig. 2

A and B, Contrast-enhanced chest CT (LightSpeed 16, General Electric Medical Systems, Milwaukee, WI) with coronal reconstruction and 3D CT shows abrupt interruption of the right interlobar artery (white arrow) without endoluminal changes, and a normal-sized right main pulmonary artery and right upper lobe artery. There is no evidence of multiple bilateral pulmonary arterial abnormalities usually seen in chronic pulmonary thromboembolism. C, Contrast-enhanced chest CT with coronal reconstruction shows prominent right inferior phrenic artery (white arrow).

Fig. 3

High-resolution CT (HRCT) demonstrates ground-glass opacities, reticular changes, and small cysts (black arrows) in the right lower lobe suggesting a unilateral involvement of the interstitial lung abnormality changes.

Fig. 4

Lung perfusion scan shows total defect in the right middle and lower lobes (black arrow).

Chest radiograph shows reticular opacities in the right middle and lower lung field without volume change. A and B, Contrast-enhanced chest CT (LightSpeed 16, General Electric Medical Systems, Milwaukee, WI) with coronal reconstruction and 3D CT shows abrupt interruption of the right interlobar artery (white arrow) without endoluminal changes, and a normal-sized right main pulmonary artery and right upper lobe artery. There is no evidence of multiple bilateral pulmonary arterial abnormalities usually seen in chronic pulmonary thromboembolism. C, Contrast-enhanced chest CT with coronal reconstruction shows prominent right inferior phrenic artery (white arrow). High-resolution CT (HRCT) demonstrates ground-glass opacities, reticular changes, and small cysts (black arrows) in the right lower lobe suggesting a unilateral involvement of the interstitial lung abnormality changes. Lung perfusion scan shows total defect in the right middle and lower lobes (black arrow).

Discussion

To the best of our knowledge, there is only one case report on the CT findings of an isolated congenital interruption of the right interlobar pulmonary artery [1]. Chest radiographic findings showed a normal lung volume, fine reticular opacities in the right middle and lower lung field, and similar size of both hilum. Chest CT findings were described as UIP pattern-like changes such as bronchial dilatation, ground-glass opacities, reticular changes, and honeycomb cysts in the right middle and lower lobes. Multiple enlarged collateral systemic arteries without patent ductus arteriosus were also observed. The pathophysiology for this condition may be related to the partial involution of the proximal sixth aortic arch [1]. The blind end of the pulmonary artery at the hilum may cause the anastomoses of pulmonary vessels to systemic arteries. The idiopathic pulmonary fibrosis-like changes seen are thought to represent lung injury (i.e., ischemia, infarction, bleeding and inflammatory change) caused by the pressure gradient between these vessels or a high oxygen saturation level [1]. Our patient also had an enlarged inferior phrenic artery distributed to the right lower lobe, but the pulmonary parenchymal change was thought to be different from the previous case. The difference in the CT appearance between our patient and the previously reported case was probably due to the difference in the grade of the lung injury. The most important differential diagnosis was chronic PE in which the presence of multiple bilateral arterial abnormalities and occlusion of one main pulmonary artery mimic proximal interruption, which has been reported in only 3% of cases [2,3]. Our patient did not manifest these findings and warfarin therapy was not effective. Other differential diagnoses were pulmonary artery involvement in Takayasu's arteritis or Behçet's disease, for which our patient did not meet the diagnostic criteria [4,5].

Conclusion

We describe the rare case of unilateral interstitial lung abnormality due to isolated congenital interruption of the right interlobar pulmonary artery. We believe that our case will add to our understanding and recognition of the spectrum of this rare condition.
  5 in total

1.  Congenital absence of the right interlobar pulmonary artery: HRCT findings.

Authors:  Dae Shick Ryu; Jae Hong Ahn; Soo Jung Choi; Jong-hyek Lee; Seung Mun Jung; Man Soo Park; Bok-hyeon Jung
Journal:  J Thorac Imaging       Date:  2008-11       Impact factor: 3.000

2.  Isolated pulmonary arteries involvement in a patient with Takayasu's arteritis.

Authors:  O Brugiere; H Mal; C Sleiman; O Groussard; F Mellot; M Fournier
Journal:  Eur Respir J       Date:  1998-03       Impact factor: 16.671

3.  Chronic thromboembolic occlusion in the adult can mimic pulmonary artery agenesis.

Authors:  K M Moser; L K Olson; M Schlusselberg; P O Daily; W P Dembitsky
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

4.  Pulmonary involvement in Behçet's disease.

Authors:  Oğuz Uzun; Levent Erkan; Ilkser Akpolat; Serhat Findik; Atilla Guven Atici; Tekin Akpolat
Journal:  Respiration       Date:  2007-04-20       Impact factor: 3.580

5.  CT diagnosis of chronic pulmonary thromboembolism.

Authors:  Eva Castañer; Xavier Gallardo; Eva Ballesteros; Marta Andreu; Yolanda Pallardó; Josep Maria Mata; Lluis Riera
Journal:  Radiographics       Date:  2009 Jan-Feb       Impact factor: 5.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.